MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss, basic
-$18,866K
(-65.46%↓ Y/Y)
Net loss
-$18,866K
Interest income
$787K
(54.92%↑ Y/Y)
Other income, net
$565K
(-83.82%↓ Y/Y)
US
$24,387K
(31.57%↑ Y/Y)
EMEA
$10,765K
(-6.93%↓ Y/Y)
Asia Pacific
$7,751K
(-12.82%↓ Y/Y)
Other
$1,232K
(-50.02%↓ Y/Y)
Loss before income
taxes
-$17,373K
Provision for income taxes
$1,493K
(997.79%↑ Y/Y)
Total other income,
net
$1,090K
(-70.61%↓ Y/Y)
Total revenue, net
$44,135K
(6.46%↑ Y/Y)
Interest expense
$262K
(-9.97%↓ Y/Y)
Loss from operations
-$18,463K
(-23.29%↓ Y/Y)
Gross profit
$21,254K
(5.44%↑ Y/Y)
Total cost of sales
$22,881K
(7.42%↑ Y/Y)
Total operating
expenses
$39,717K
(13.05%↑ Y/Y)
General and
administrative
$18,467K
(43.18%↑ Y/Y)
Sales and marketing
$11,646K
(-6.90%↓ Y/Y)
Research and development
$9,604K
(-1.24%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Cytek Biosciences, Inc. (CTKB)
Cytek Biosciences, Inc. (CTKB)